Meridian Bioscience Inc expected to post earnings of 21cents a share - Earnings Preview

VivoPower

31/01/2023 19:31

* Meridian Bioscience Inc  VIVO.OQ   VIVO.O  is expected
to show a
fall in quarterly revenue when it reports  results on February 2
(estimated). 
    * The Cincinnati Ohio-based  company is expected to report 
a
18.1% decrease in revenue to $72.311 million from $88.34 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Meridian Bioscience
Inc
is for earnings of 21 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Meridian
Bioscience Inc is $34​, above​ its last closing price of $33.97.
​​​

This summary was machine generated January 31 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated